SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement- Notice of Postal Ballot.26-02-2022
26-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Submission of Notice of Postal Ballot25-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Re-Schedule Of Conference Call For The Investors And Analysts
Re-schedule of Conference Call for the Investors and Analysts18-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Update on Resignation of Company Secretary & Compliance Officer as per Regulation 30 of SEBI (LODR) Regulations, 201516-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Appointment of Company Secretary and Compliance Officer
In continuation to the intimation dated 9th February, 2022, regarding the appointment of Company Secretary & Compliance Officer of the Company, we would like to inform you that Mr. Tirumalesh Tumma, will be joining the office with effect from 16th February, 2022. The details required under Regulation 30 of the Listing Regulations, read with SEBI Circular No. CIR/CFO/CMD/4/2015 dated September 09, 2015 is given in the enclosed as Annexure. We request you to please take the same on Record.14-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Intimation Of Conference Call Regulation 30(6) Of SEBI (LODR) Regulation, 2015
This is to inform you that conference call for investors and Analysts has been scheduled on Friday 18th February, 2022 at 11.00 AM11-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Press Release And Investor Presentation
Please find attached the press release and Investor presentation against the Financial Results for the quarter ended 31st December, 2021.10-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - PUBLICATION OF FINANCIAL RESULTS IN NEWSPAPER.
Further to our intimation dated February 9th, 202 2. Please find enclosed herewith copies of the newspaper advertisements published in Financial Express and Andhra Prabha on 10th February, 2022, regarding financial results for quarter and nine months ended 31st December, 202 1. Please note that this information is published within 48 hours of closure of the Board meeting as specified in Regulation 47(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.10-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Outcome Of Board Meeting Held On 9Th February, 2022
With reference to the above subject, we would like to inform you that Board of Directors of the Company at their meeting held today, inter-alia considered and approved the following: 1. The Standalone and Consolidated Un-audited Financial Results for the third Quarter and Nine months ended 31st December, 2021 along with the Limited Review Report.09-02-2022
SMS PHARMACEUTICALS LTD. - 532815 - Board Meeting Intimation for Notice Of Board Meeting To Be Held On 09.02.2022
SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 ,inter alia, to consider and approve NOTICE is hereby given pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 that a meeting of the Board of Directors of the Company will be held on the Wednesday, 9th day of February, 2022, at the Registered Office of the Company, inter alia, for the following items: To consider and approve the Un-audited Standalone and Consolidated Financial results of the Company for the Quarter and nine months ended as on 31st December, 2021. Please be informed that Insider Trading window of SMS Pharmaceuticals Limited shall remain closed till 11th February, 2022 in view of the above mentioned Board Meeting.03-02-2022